Searched for
KNEE IMPLANT FAILURE
Robotic joint replacement surgery and insurance: The gap patients should know aboutRobotic surgery offers better outcomes for knee and hip pain patients. However, many Indians cannot access this advanced treatment due to i...- Recurring pain while walking? Your knee, hip implants might have expired; experts flag warning signs that you should not ignoreDo you experience recurring pain or feel difficulty while walking? It could be a sign that your knee or hip implants need to be replaced. D...
- Alkem joins $3 bn race for JB Chem as Torrent pauses talksAlkem Laboratories, India's fifth-largest branded pharmaceutical company, is vying for JB Chemicals and Pharmaceuticals as KKR looks to sel...
- Could Donald Trump's maiden India visit become all show, no business?High tariffs and trade deficit with India are a constant refrain of Trump’s bashing of India as ‘tariffs king’.
- Finally, a govt side story to quell India's misgivings about ModicareAyushman Bharat has both supporters who are inspired by the vision and detractors who harbour many doubts.
- Hopeful of settlement between India and US over GSP conflict: AdvamedIn 2017 India was the biggest beneficiary of GSP with a subsidies worth $5.6 billion.
- This government is going to be re-elected with an even better result than last time: Piyush GoyalVision, not ownership defines success of any business and organisation, says Goyal.
- US firms approach USTR against India's medical price control measuresAdvanced Medical Technology Association president Scott Whitaker requested the USTR to 'suspend or withdraw' India's benefits under General...
- Reuters Sports News SummarySPORTS:Reuters Sports News Summary
- Technology makes total hip replacement feasible for young too: Dr Francesco Falez, Hospital of Santo Spirito"Compared to earlier times, surgeons know what to do if an implant fails. Patients are also becoming more confident of procedures."
- How Piramal Healthcare is trying to build an entire business around discovering new drugsPiramal's game plan is to add to this portfolio by buying more molecules in late stages of development in niche segments.
Load More
